Manager, Analytical Development

Redwood City, California, United States · On-site$161k – $189k

About this role

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.

Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. 

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com.

This position, reporting to the Sr. Director of Analytical Development and Quality Control, will be responsible for supporting analytical development activities for pharmaceutical drug substances and products.

Responsibilities:

  • Provide analytical development support for drug substance and drug product manufacturing activities at Contract Manufacturing Organizations (CMOs), including development projects and routine manufacturing operations
  • Review documents associated with drug substance and product development and manufacturing, including but not limited to change controls, methods, monographs, protocols, and reports, and organize and archive documents in Veeva Quality Docs System
  • Review analytical raw data in support of batch release and stability studies
  • Assist in authoring relevant sections, including formatting and structuring of data, in support of regulatory filings
  • Assist in drafting, formatting, and routing of SOPs for analytical development and quality control
  • When needed, provide administrative support for activities related to analytical development

Preferred Skills, Qualifications and Technical Proficiencies:

  • Working knowledge of documents related to GMP and development regarding Analytical Development and Quality Control
  • Must have high proficiency in use of MS Office applications (Word, Excel, PowerPoint)
  • Detail-oriented, highly organized, good initiative with a customer-service attitude. Enjoy working independently

Preferred Education and Experience:

  • BA/BS degree in a scientific/technical/engineering field
  • 6-8 years’ experience in Pharmaceutical Manufacturing and/or Analytical Development and/or Quality Control or equivalent

The pay range that the Company reasonably expects to pay for this headquarters-based position is $160,600 – $189,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

 Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview.  Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

 

Company at a glance

We’ve been unlocking the potential of cortisol modulation for more than 25 years.

We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Founded1998
Team Size501-1,000 employees
WorkspaceOn-site
IndustryBiotechnology Research
Location
Redwood City, California, United States
LinkedInLinkedIn

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

Know someone who'd be great for this?